Does BRIGATINIB Cause Malignant neoplasm progression? 73 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 73 reports of Malignant neoplasm progression have been filed in association with BRIGATINIB (Alunbrig). This represents 2.2% of all adverse event reports for BRIGATINIB.
73
Reports of Malignant neoplasm progression with BRIGATINIB
2.2%
of all BRIGATINIB reports
11
Deaths
6
Hospitalizations
How Dangerous Is Malignant neoplasm progression From BRIGATINIB?
Of the 73 reports, 11 (15.1%) resulted in death, 6 (8.2%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BRIGATINIB. However, 73 reports have been filed with the FAERS database.
What Other Side Effects Does BRIGATINIB Cause?
Death (405)
Non-small cell lung cancer (370)
Off label use (256)
Diarrhoea (239)
Metastases to central nervous system (219)
Nausea (218)
Lung neoplasm malignant (216)
Fatigue (201)
Blood creatine phosphokinase increased (198)
Product dose omission issue (193)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which BRIGATINIB Alternatives Have Lower Malignant neoplasm progression Risk?
BRIGATINIB vs BRILINTA
BRIGATINIB vs BRILIQUE
BRIGATINIB vs BRIMONIDINE
BRIGATINIB vs BRIMONIDINE\BRINZOLAMIDE
BRIGATINIB vs BRIMONIDINE\TIMOLOL